Overexpression of the GPX2 gene is observed in many cancers, such as breast [14], liver [15], gastric [16], colorectal [17], nasopharyngeal [18], and esophageal squamous cell carcinoma [19], as well as in premalignant lesions like Barrett's esophagus [20]. This evidence concerns the gene GPX2 and cancer.